Suggestions
Claire Novorol
Co-founder and Chief Medical Officer at Ada Health
Claire Novorol is a prominent figure in the healthcare technology industry with extensive experience as both a medical professional and entrepreneur. Here's an overview of her background and current roles:
Professional Experience
Claire Novorol is the Co-founder and Chief Medical Officer of Ada Health, a position she has held since May 2012.12 Ada Health is a health tech company that uses AI for disease detection and diagnosis. In this role, she oversees medical quality and leads the medical teams, ensuring that their products meet the needs of patients and healthcare professionals.1
Medical Background
Dr. Novorol is a trained medical doctor with a strong academic background:
- She worked as a pediatrician in London before specializing in clinical genetics.1
- She earned a degree in both pathology and medicine from the University of Bristol.2
- She holds a PhD in neuroscience from the University of Cambridge.12
Entrepreneurial Activities
Beyond her work at Ada Health, Claire Novorol is involved in various entrepreneurial and advisory roles:
- She is the founder of Doctorpreneurs, an organization she started in August 2011.2
- She serves as an oNetwork Expert Advisor at Saïd Business School, University of Oxford.2
- She has been a mentor for the Creative Destruction Lab and the University of St.Gallen START Fellowship.2
Investing Activities
Claire Novorol is also active as an angel investor:
- She has made investments in health tech startups, including Una Health.34
- Her most recent investment was in Una Health's Seed round on February 14, 2024.4
Current Roles
In addition to her position at Ada Health, Claire Novorol holds the following roles:
Claire Novorol's LinkedIn username is indeed clairenovorol, as mentioned in the query.2
Highlights
Heading out of Austin following a couple of fun days at #SXSW. Many thanks to American Medical Association President, Jesse Ehrenfeld MD MPH, for moderating our session on AI in Healthcare, and to my co-panelists Mark Sendak of the Duke Institute For Health Innovation and Alex Stinard, MD of Envision Healthcare for an excellent discussion. #aiinhealthcare #sxsw
Kicking off 2024 with this excellent overview of the tremendous opportunity our industry has to leverage technology and #AI to shorten the path to diagnosis, care and treatment. I really enjoyed speaking with Stephanie Cain at Fortune about Ada’s commitment to making the experience of symptom self-assessment more personalized, granular and reliable - often preventing the anxiety and burden that comes with unnecessary and costly emergency care. As our industry continues to experiment with #AI and #LLMs to reduce clinician burnout and administrative burden the benefits also extend well beyond the patient experience.
